Purity: | 99 % |
---|---|
Model Number: | CAS NO.: 10161-34-9 |
Brand Name: | NJBN |
Grade Standard: | Medicine Grade |
Type: | Central Nervous System Agents, |
Place of Origin: | China (Mainland) |
EINECS No.: | 233-432-5 |
MF: | C20H24O3 |
CAS No.: | 171599-83-0 |
Quick Details
Specifications
Effevtive Pure Natural Steroid Hormones CAS 171599-83-0 Sildenafil Citrate
keyword : steroid powder , steroid raw powder , raw steroid supplier , steroid injection , steroid hormone , anabolic steroid , hormone , testosterone enanthate ,trenbolone acetate , testosterone cypionate , pharmaceutical raw material , pharmaceutical chemical , boldenone undecylenate , methenolone acetate , weight loss , dianabol , winstrol , clomid , Nolvadex
--- Sex Steroid Hormones Quick Detail ---
- Sildenafil Citrate
- Synonyms : din-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-,2-hydroxy-1,2,3-propanetricarbo ; piperazine,1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo(4,3-d)pyrimi;piperazine,1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-,2-hydroxy-1,2,3-propanetricarboxylate(1:1) ; uk92480-10;SILDENAFIL CITRATE ; VIAGRA ; 1-[[3-(4,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)-4-ETHOXYPHENYL]SULFONYL]-4-METHYLPIPERAZINE, CITRATE;1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate
- CAS Number : 171599-83-0
- MF : C28H38N6O11S
- MW : 666.7
- Purity : 99 %
- Appearance : White Solid Powder
- Usage : An orally active selective type 5 cGMP phosphodiesterase inhibitor ; Agent ; Enzyme inhibitor
- Product Categories : Sex Steroid Hormones ; Intermediates & Fine Chemicals ; Pharmaceuticals ; Sildenafil ; Pfizer compounds ; Inhibitor ; Viagra , Revatio ; Inhibitors
--- Sex Steroid Hormones Description ---
- Sildenafil is a drug used to treat erectile dysfunction and PAH .
- Sildenafil, sold as Viagra , Revatio and under various other trade names , is a drug used to treat erectile dysfunction and pulmonary arterial hypertension ( PAH ) . It acts by inhibiting cGMP-specific phosphodiesterase type 5 ( PDE5 ) , an enzyme that promotes degradation of cGMP, which regulates blood flow in the penis. Since becoming available in 1998 , sildenafil has been the prime treatment for erectile dysfunction ; its primary competitors on the market are tadalafil ( Cialis ) and vardenafil ( Levitra ) .
- Sildenafil Citrate is solely active in relaxing muscles and increasing blood flow to the heart , lungs and penis due to PDE-5 , yet vasodilation is not increased in other parts of the body .Technical Data : In studies where Viagra was administered to over 3700 patients , 19-87 years old in world wide clinical trials . More than 550 patients received treatment post 1 year . 2.5% of the Viagra subjects and 2.3% of the placebo subjects reported adverse effects , which were all considered mild . These reported side effects included abnormal or blurred vision and increased sensitivity to light . All other negative reactions reported , including URI , flu symptoms , back pain and arthralgia, occurred at a rate of less than 2% and equally common in the placebo and Viagra administered groups .
- Effects worsened and were reported more frequently as dosages increased.Other studies measured duration of sexually stimulated erection using a Rigiscan device . Duration of rigidity was increased by 60% with Viagra use .
MALE SEXUAL ENHANCEMENT POWDERS:
Sildenafil citrate CAS:171599-83-0
Dapoxetine hydrochloride CAS:129938-20-1
Cialis (Tadalafil) CAS:171596-29-5
Vardenafil CAS:224785-91-5
Yohimbine HCl CAS:65-19-0
Flibanserin (Female Viagra) CAS:167933-07-5
Amino Tadalafil CAS:385769-84-6